©The Author(s) 2016.
World J Gastroenterol. Sep 14, 2016; 22(34): 7625-7644
Published online Sep 14, 2016. doi: 10.3748/wjg.v22.i34.7625
Published online Sep 14, 2016. doi: 10.3748/wjg.v22.i34.7625
Table 1 Pathogenesis of micronutrient deficiency in inflammatory bowel disease
| Decreased food intake |
| Anorexia (TNF-mediated) |
| Mechanical (fistulas, post-operative) |
| Avoidance of high-residue food (can worsen abdominal pain/diarrhea) |
| Avoidance of lactose-containing foods (high rates of concomitant lactose intolerance) |
| Increased intestinal loss |
| Diarrhea (increased loss of Zn2+, K+, Mg2+) |
| Occult/overt blood loss (iron deficiency) |
| Exudative enteropathy (protein loss, and decrease in albumin-binding proteins) |
| Steatorrhea (fat and fat-soluble vitamins) |
| Malabsorption |
| Loss of intestinal surface area from active inflammation, resection, bypass or fistula |
| Terminal ileal disease associated with deficiencies in B12 and fat-soluble vitamins |
| Hypermetabolic state |
| Alterations of resting energy expenditure |
| Drug interactions |
| Sulfasalazine and methotrexate inhibits folate absorption |
| Glucocorticoids impair Ca2+, Zn2+, and phosphorus absorption, vitamin C losses and vitamin D resistance |
| Cholestyramine impairs absorption of fat-soluble vitamins, vitamin B12 and iron |
| Long-term total parenteral nutrition |
| Can occur with any micronutrient not added to TPN |
| Reported deficiencies include thiamine, vitamin, and trace elements Zn2+, Cu2+, selenium, chromium |
- Citation: Abegunde AT, Muhammad BH, Ali T. Preventive health measures in inflammatory bowel disease. World J Gastroenterol 2016; 22(34): 7625-7644
- URL: https://www.wjgnet.com/1007-9327/full/v22/i34/7625.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i34.7625